Observational studyMicrobiology spectrum2026
PK/PD study of vancomycin in enterococcal infections: efficacy and safety assessment under the guidance of TDM.
Hongyan Zhu, Jingli Liao, Wei Wu, Fenfen Gu, Tong Zhu, Xiaohui Huang, Jian Zhang, Lixia Li
Abstract readObservational Study
In one paragraphObservational study in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Hongyan Zhu *Department of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID 0009-0009-4739-2287 Jingli Liao *Department of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wei Wu *Department of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Fenfen GuDepartment of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Tong ZhuDepartment of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xiaohui HuangDepartment of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jian ZhangDepartment of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID 0000-0003-2921-1015 Lixia LiDepartment of Clinical Pharmacy, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID 0000-0001-8171-9217 Funding
National Natural Science Foundation of China 82405155
6 · The paper itselfAbstract
Vancomycin is widely utilized in the treatment of
Indexed as
Anti-Bacterial AgentsEnterococcusGram-Positive Bacterial InfectionsVancomycinAcute Kidney InjuryAdultAgedAged, 80 and overArea Under CurveFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsVancomycinEnterococcusindividualized therapypharmacokinetics/pharmacodynamics (PK/PD)therapeutic drug monitoring (TDM)vancomycin
Identifiers
PMID42294720
PMCPMC13339812
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390